John Odom
Family Medicine · Mullins, SCNPI 1003889387
Payments from drug & device makers
Across 590 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1K
- AbbVie$1K
- AstraZeneca$905
- Pfizer$587
- Novo Nordisk$527
- Lilly USA, LLC$504
- plus $4K from 36 others
What the payments were for
- Food & beverage$8,81699%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,916 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 364 | $334,517 |
| MounjaroTirzepatide | 174 | $198,205 |
| EliquisApixaban | 239 | $181,534 |
| OzempicSemaglutide | 115 | $136,588 |
| LinzessLinaclotide | 138 | $119,456 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 92 | $79,405 |
| TrulicityDulaglutide | 63 | $78,271 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 93 | $74,261 |
| JanuviaSitagliptin Phosphate | 71 | $65,872 |
| FarxigaDapagliflozin Propanediol | 55 | $50,432 |
| XareltoRivaroxaban | 29 | $40,564 |
| EntrestoSacubitril/Valsartan | 44 | $36,559 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 53 | $36,196 |
| TradjentaLinagliptin | 32 | $33,399 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $27,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Combivent Respimat, Trijardy Xr | $1,314 | $395,382435 claims |
| Lilly USA, LLCMounjaro, Trulicity | $504 | $276,476237 claims |
| PfizerEliquis | $587 | $181,534239 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Brilinta | $905 | $144,827193 claims |
| Novo NordiskOzempic | $527 | $136,588115 claims |
| AbbVieLinzess, Ubrelvy | $1,045 | $134,313152 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $294 | $91,172107 claims |
| MerckJanuvia, Janumet Xr | $280 | $88,36192 claims |
| Johnson & JohnsonXarelto | $204 | $40,56429 claims |
| NovartisEntresto | $329 | $36,55944 claims |
| Astellas Pharma US IncMyrbetriq | $236 | $18,27428 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $328 | $7,43313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Mullins
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.